ConductScience.org, home

Paper14647405

CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers.

Fukuda T and 11 others. Pharmacogenomics J, 2004. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers. Papers, record 14647405. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14647405

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers.
PubMed
Journal
Pharmacogenomics J
PubMed
Year
2004
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.14
iCite
Revised in PubMed
2026-10-10
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fukuda TT
2Onishi SS
3Fukuen SS
4Ikenaga YY
5Ohno MM
6Hoshino KK
7Matsumoto KK
8Maihara AA
9Momiyama KK
10Ito TT
11Fujio YY
12Azuma JJ

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytochrome P-450 Enzyme SystemMajor topic
NifedipineMajor topic
Adult
Analysis of Variance
Area Under Curve
Cytochrome P-450 CYP3A
Female
Genotype
Humans
Male

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111502729Genetic polymorphism of cytochrome P450 3A5 in Chinese.Drug Metab Dispos2001https://conductscience.org/library/papers/11502729PubMed
212042671Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population.Pharmacogenetics2002https://conductscience.org/library/papers/12042671PubMed
38561495Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.Arch Biochem Biophys1996https://conductscience.org/library/papers/8561495PubMed
410213372Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.Pharm Res1999https://conductscience.org/library/papers/10213372PubMed
59328287
Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
Arch Biochem Biophys1997https://conductscience.org/library/papers/9328287PubMed
611231118Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport.Eur J Pharm Sci2001https://conductscience.org/library/papers/11231118PubMed
711740341The genetic determinants of the CYP3A5 polymorphism.Pharmacogenetics2001https://conductscience.org/library/papers/11740341PubMed
88035341Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.J Pharmacol Exp Ther1994https://conductscience.org/library/papers/8035341PubMed
912124305Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.Drug Metab Dispos2002https://conductscience.org/library/papers/12124305PubMed
1010511065Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4.Clin Pharmacol Ther1999https://conductscience.org/library/papers/10511065PubMed
113203042The pharmacokinetics of oral nifedipine--a population study.Br J Clin Pharmacol1988https://conductscience.org/library/papers/3203042PubMed
126746815Liquid chromatographic determination of nifedipine in plasma and of its main metabolite in urine.J Chromatogr1984https://conductscience.org/library/papers/6746815PubMed
1312065767Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism.Mol Pharmacol2002https://conductscience.org/library/papers/12065767PubMed
1412228187Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.Drug Metab Dispos2002https://conductscience.org/library/papers/12228187PubMed
157826796Midazolam is metabolized by at least three different cytochrome P450 enzymes.Br J Anaesth1994https://conductscience.org/library/papers/7826796PubMed
1610898107Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method.Pharmacogenetics2000https://conductscience.org/library/papers/10898107PubMed
1712413960Identification of the novel splicing variants for the hPXR in human livers.Biochem Biophys Res Commun2002https://conductscience.org/library/papers/12413960PubMed
1812756208Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism.Drug Metab Dispos2003https://conductscience.org/library/papers/12756208PubMed
199923580Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects.Eur J Clin Pharmacol1998https://conductscience.org/library/papers/9923580PubMed
202732228
Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine.
J Biol Chem1989https://conductscience.org/library/papers/2732228PubMed

See all 28 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
29947950Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans.Eur J Clin Pharmacol2018https://conductscience.org/library/papers/29947950PubMed
23835882A Semi-Mechanistic Metabolism Model of CYP3A Substrates in Pregnancy: Predicting Changes in Midazolam and Nifedipine Pharmacokinetics.CPT Pharmacometrics Syst Pharmacol2012https://conductscience.org/library/papers/23835882PubMed
22875663Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic.Am J Perinatol2013https://conductscience.org/library/papers/22875663PubMed
21836356Inferences from targeting CYP450 modulation to decrease the risk of induced cataract in the experimental model?Indian J Ophthalmol2011https://conductscience.org/library/papers/21836356PubMed
19907160CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease.Am J Nephrol2010https://conductscience.org/library/papers/19907160PubMed
19205682Effects of CYP3A5, MDR1 and CACNA1C polymorphisms on the oral disposition and response of nimodipine in a Chinese cohort.Eur J Clin Pharmacol2009https://conductscience.org/library/papers/19205682PubMed
19076156Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa.Br J Clin Pharmacol2009https://conductscience.org/library/papers/19076156PubMed
18385991Effect of CYP3A5*3 genotype on the pharmacokinetics and antiplatelet effect of clopidogrel in healthy subjects.Eur J Clin Pharmacol2008https://conductscience.org/library/papers/18385991PubMed
18214455Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMs.Eur J Clin Pharmacol2008https://conductscience.org/library/papers/18214455PubMed
16638735Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition.J Clin Pharmacol2006https://conductscience.org/library/papers/16638735PubMed
16430309Significance of the minor cytochrome P450 3A isoforms.Clin Pharmacokinet2006https://conductscience.org/library/papers/16430309PubMed
15483658Importance of patient selection when determining the significance of the CYP3A5 polymorphism in clinical trials.Pharmacogenomics J2004https://conductscience.org/library/papers/15483658PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
CYP3A51577PubTator's text mininghttps://conductscience.org/library/genes/1577NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14647405

GET https://conductscience.org/api/papers/v1/14647405/references?page=2